| 266 |
increased |
apoptotic process
(GO:0006915)
|
|
3 Events
|
| 265 |
decreased |
hormone biosynthetic process
(GO:0042446)
|
testosterone
(CHEBI:17347)
|
2 Events
|
| 264 |
decreased |
reproductive process
(GO:0022414)
|
|
675: Reduced, Reproductive Success
|
| 263 |
decreased |
|
prostaglandin
(CHEBI:26333)
|
685: Reduced, Prostaglandins, ovary
|
| 262 |
decreased |
ovulation
(GO:0030728)
|
|
488: Decrease, Ovulation
|
| 261 |
increased |
signaling
(GO:0023052)
|
RAC-beta serine/threonine-protein kinase
(PR:000003912)
|
484: Activation, AKT2
|
| 260 |
occurrence |
inflammatory response
(GO:0006954)
|
|
486: systemic inflammation leading to hepatic steatosis
|
| 259 |
increased |
gene expression
(GO:0010467)
|
apolipoprotein B-100
(PR:000004145)
|
880: Increased, ApoB100
|
| 258 |
increased |
signaling
(GO:0023052)
|
microsomal triglyceride transfer protein large subunit MTTP
(PR:000003392)
|
879: Activation, MTTP
|
| 257 |
decreased |
catalytic activity
(GO:0003824)
|
17-beta-hydroxysteroid dehydrogenase 14
(PR:000008778)
|
482: Decreased, DHB4/HSD17B4
|
| 256 |
increased |
signaling
(GO:0023052)
|
nuclear receptor subfamily 0 group B member 2
(PR:000011391)
|
480: Activation, SHP
|
| 255 |
increased |
signaling
(GO:0023052)
|
bile acid receptor
(PR:000011396)
|
479: Activation, NR1H4
|
| 254 |
increased |
signaling
(GO:0023052)
|
nuclear factor erythroid 2-related factor 2
(PR:000011170)
|
478: Activation, NRF2
|
| 253 |
increased |
biosynthetic process
(GO:0009058)
|
triglyceride
(CHEBI:17855)
|
2 Events
|
| 252 |
decreased |
gene expression
(GO:0010467)
|
hydroxymethylglutaryl-CoA synthase, mitochondrial
(PR:000008638)
|
474: Down Regulation, HMGCS2
|
| 251 |
decreased |
gene expression
(GO:0010467)
|
carnitine O-palmitoyltransferase 1, liver isoform
(PR:000005835)
|
472: Down Regulation, CPT1A
|
| 250 |
decreased |
signaling
(GO:0023052)
|
hepatocyte nuclear factor 3-beta
(PR:000007603)
|
471: Inhibition, FoxA2
|
| 249 |
decreased |
signaling
(GO:0023052)
|
hepatocyte nuclear factor 4-alpha
(PR:000008654)
|
461: Suppression, HNF4alpha
|
| 248 |
increased |
acetyl-CoA carboxylase activity
(GO:0003989)
|
acetyl-CoA carboxylase 1
(PR:000003596)
|
470: Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)
|
| 247 |
increased |
gene expression
(GO:0010467)
|
fatty acid synthase
(PR:000007348)
|
463: Up Regulation, FAS
|
| 246 |
increased |
triglyceride biosynthetic process
(GO:0019432)
|
triglyceride
(CHEBI:17855)
|
454: Increased, Triglyceride formation
|
| 245 |
increased |
signaling
(GO:0023052)
|
sterol regulatory element-binding protein 1
(PR:000015611)
|
457: Activation, SREBF1
|
| 244 |
decreased |
signaling
(GO:0023052)
|
nuclear receptor subfamily 1 group I member 3
(PR:000011398)
|
456: Suppression, Constitutive androstane receptor, NR1l3
|
| 243 |
increased |
gene expression
(GO:0010467)
|
cytochrome P450 1A1
(PR:000006101)
|
80: Up Regulation, CYP1A1
|
| 242 |
increased |
receptor-mediated endocytosis
(GO:0006898)
|
low-density lipoprotein
(CHEBI:39026)
|
467: Increased, LDL uptake
|